A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease.
Thomas T. et al, (2024), Nat Immunol, 25, 2152 - 2165
Neurodegenerative fluid biomarkers are enriched in human cervical lymph nodes.
Al-Diwani A. et al, (2024), Brain
Human tonsil organoids reveal innate pathways modulating humoral and cellular responses to ChAdOx1
Pudjohartono MF. et al, (2024)
Dysregulated immunologic landscape of the early host response in melioidosis.
Rongkard P. et al, (2024), JCI Insight, 9
Species-level, metagenomic and proteomic analysis of microbe-immune interactions in severe asthma
Jabeen M. et al, (2024), Allergy
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity.
Amini A. et al, (2024), Curr Opin Virol, 67
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.
Citarella BW. et al, (2024), Heliyon, 10
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.
Liu C. et al, (2024), Cell Rep Med, 5
MAIT cell-MR1 reactivity is highly conserved across multiple divergent species.
Edmans MD. et al, (2024), J Biol Chem
Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients.
González Cueto E. et al, (2024), Inflamm Bowel Dis, 30, 859 - 862
Fine needle aspiration of human lymph nodes reveals cell populations and soluble interactors pivotal to immunological priming.
Provine NM. et al, (2024), Eur J Immunol, 54
Neurodegenerative fluid biomarkers are enriched in human cervical lymph nodes
Al-Diwani A. et al, (2024)
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease.
Drury RE. et al, (2024), Nat Commun, 15
Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery.
Ali M. et al, (2024), Clin Exp Immunol
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Liu C. et al, (2024), Nat Commun, 15
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Zhou D. et al, (2024), Nat Commun, 15
IL-5 antagonism reverses priming and activation of eosinophils in severe eosinophilic asthma.
Luo J. et al, (2024), Mucosal Immunol
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution.
Ng MTH. et al, (2024), Nat Commun, 15